AirSculpt Technologies, Inc. (AIRS)
$1.62-2.41%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $114M
- Beta
- 2.32
- P/E (TTM)
- -10.24
- Short % float
- 20.08%
- Days to cover
- 3.3
- SI change
- -2.1%
- 1W
- -8.47%
- 1M
- -32.50%
- vs SPY 1W
- -9.63%
- vs SPY 1M
- -35.49%
Industry peers
FMP comparable companies · ranked by market cap
- CMPSSELLCOMPASS Pathways plc$1.5BCRISISQ -3$11.47+4.62%
- AMNBUYAMN Healthcare Services, Inc.$1.4BBULLQ 21$35.44+3.05%
- INNVSELLInnovage Holding Corp.$1.2BCRISISQ 14$9.11-0.11%
- MLTXSELLMoonLake Immunotherapeutics$890MCRISISQ -0$10.58+2.27%
- SIBNBUYSI-BONE, Inc.$836MBULLQ 5$18.86+2.70%
- PACBBUYPacific Biosciences of California, Inc.$714MCRISISQ 4$2.30+1.30%
- AQSTSELLAquestive Therapeutics, Inc.$597MRECOVERYQ -4$4.76+0.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AIRS?
- LOPJLB’s latest quantitative signal on AirSculpt Technologies, Inc. (AIRS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AIRS in?
- AirSculpt Technologies, Inc. (AIRS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does AirSculpt Technologies, Inc. (AIRS) do?
- AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasiv…